| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Zeke Zhu CEO | HKEX Exchange | KYG7360A1094 ISIN |
| China Country | 214 Employees | - Last Dividend | - Last Split | - IPO Date |
Rainmed Medical Limited is a pioneer in the field of vascular interventional surgical robotics, with operations extending from China to the international scene. Since its inception in 2014, the company has dedicated itself to the innovation and advancement of medical instruments that facilitate less-invasive cardiovascular diagnostics and interventions. Its focus is on leveraging technological breakthroughs to improve the precision and safety of procedures such as coronary angiography, making significant strides in the diagnosis and treatment of coronary artery diseases.
This product suite from Rainmed Medical enables a minimally invasive physiological assessment of the severity of coronary artery ischemia using coronary angiography images. Tailored to deliver accurate diagnostics without the need for more invasive procedures, these systems symbolize a leap forward in cardiovascular care, making the process more comfortable and less risky for patients.
Designed to offer a less-invasive measurement of microcirculatory resistance, this product line represents Rainmed’s commitment to improving the treatment of microcirculatory lesions. By enabling the precise evaluation of microvascular resistance, these systems facilitate targeted interventions that can significantly improve patient outcomes in conditions that were previously challenging to diagnose and treat.
Currently under development, this innovative system aims to revolutionize the delivery of contrast media during angiographic procedures. By optimizing the injection process, Rainmed Medical seeks to reduce the risks associated with contrast media delivery, enhancing safety and efficacy for patients undergoing diagnostic and interventional cardiovascular procedures.
This cutting-edge system is part of Rainmed’s ambitious project to introduce robotic assistance into the realm of vascular intervention. With the potential to significantly enhance precision and reduce procedure times, this robotic navigation system is set to redefine the standards of interventional cardiology by offering greater control and accuracy.
Also in the pipeline, the Flash RDN Systems embody Rainmed Medical’s forward-thinking approach to managing resistant hypertension. By innovating in the area of renal denervation, these systems promise to offer new therapeutic avenues for patients suffering from hypertension that is difficult to control with conventional medications.